Posts by Braden Kuo, MD
-
Pneumatic Dilation for Achalasia Generally Safe in Older Adults
Braden Kuo, MD, and colleagues have demonstrated pneumatic dilation for achalasia is safer, overall, for patients ≥65 years of age than for younger patients, as periprocedural adverse events occurred in 2.6% vs. 10.9% of patients (P=0.017).
-
ChatGPT Performs Well in Answering Common Patient Questions About Colonoscopy
In the first study of its kind, Tsung-Chun Lee, MD, PhD, Braden Kuo, MD, and colleagues demonstrated that a conversational AI (ChatGPT) can provide easy-to-understand, scientifically adequate, and generally satisfactory answers to common questions about colonoscopy as determined by gastroenterologists.
-
Virtual Tai Chi Training Feasible, Effective for Patients With IBS-Constipation
Kyle D. Staller, MD, MPH, Braden Kuo, MD, and colleagues created a virtual, group-based Tai Chi program adapted for patients who have irritable bowel syndrome with constipation. In a proof-of-concept study, feasibility of recruitment was excellent, and 67% of 27 participants attended at least seven of eight sessions.
-
Review: Digital Health for Functional Gastrointestinal Disorders
Gastroenterologists at Massachusetts General Hospital are encouraging wider adoption of digital health tools to engage and manage patients who have functional gastrointestinal disorders, noting they enable more frequent patient–provider interactions and give patients greater agency over their care.
-
Google Trends Useful for Assessing Global Burden of IBS
Ryan Flanagan, MD, MPH, Braden Kuo, MD, and Kyle Staller, MD, MPH, have provided the first evidence that Google Trends can be used to investigate the global burden of a functional gastrointestinal disorder, complementing traditional epidemiologic methods.
-
Five Sessions to See at Digestive Disease Week 2021
At Digestive Disease Week 2021, clinicians and researchers from the Massachusetts General Hospital Divisions of Gastroenterology and Gastrointestinal & Oncologic Surgery present their world-leading research and innovative treatment approaches.
-
Low-dose Gabapentin Significantly Improves Symptoms of Functional Dyspepsia
In the first study of its kind, Massachusetts General Hospital researchers showed that low-dose gabapentin is an effective and well-tolerated treatment for patients presenting with functional dyspepsia.
-
Avoidant/Restrictive Food Intake Disorder Very Common with Neurogastroenterology Symptoms
Symptoms of avoidant/restrictive food intake disorder were present in nearly a quarter of patients attending a neurogastroenterology clinic.
-
Jackhammer Esophagus Very Common After Lung Transplantation
Mass General researchers have become the first to define the incidence of jackhammer (hypercontractile) esophagus after lung transplantation and identify risk factors.
-
Wireless Capsules Top Scintigraphy for Evaluating Gastroparesis Symptoms
A prospective study of concurrent gastric emptying scintigraphy and wireless motility capsules provides novel insight into how these tests influence decisions about managing suspected gastroparesis.
-
The FDA Fast-tracked Velusetrag May Be a Safer Long-term Treatment for Gastroparesis
Braden Kuo, MD, presented research that shows that the potency and selectivity of velusetrag could relieve symptoms of patients with diabetic or idiopathic gastroparesis while avoiding the harmful side effects associated with prokinetic agents often used to treat the disease.
Biography
Braden Kuo, MD, is director of the Center for Neurointestinal Health at Massachusetts General Hospital and an assistant professor of Medicine at Harvard Medical School.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.